| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |